PMID: 3756768Nov 15, 1986Paper

Vinblastine-ifosfamide-cisplatin treatment of bulky seminoma

Cancer
C ClemmW Wilmanns

Abstract

Eighteen patients with pure seminoma in advanced Stages IIC-IV of disease were treated with VIP combination chemotherapy consisting of vinblastine (6 mg/m2, days 1 and 2), ifosfamide (1.5 g/m2, days 1 to 5), and cisplatin (20 mg/m2, days 1 to 5). Eleven patients had Stage IIC, four had Stage III, three had Stage IV, and two had primary extragonadal seminoma. Primary histologic diagnoses were typical seminoma in 15 patients and anaplastic seminoma in three patients. Human chorionic gonadotropin (HCG) levels were elevated to 350 U/1 in eight patients; alpha-fetoprotein (AFP) levels were always normal. No primary lymphadenectomy was carried out. Seven of 18 patients had prior radiotherapy and were treated because of relapse or progression. There was one early death and one patient has not yet completed therapy. Of 16 evaluable patients, 14 reached complete remission (CR) (88%), which was documented surgically in six cases, whereas in the non-pretreated group, all nine patients reached CR and in the pretreated group, CR could be induced in five of seven patients (71%). The remission duration ranged from 6+ to 41+ months (median, 29+ months). No relapse has occurred. The bone marrow toxicity of VIP was remarkable. Because of leukope...Continue Reading

References

Oct 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E L FriedmanJ P Richie
Mar 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G F StantonR B Golbey
Apr 1, 1985·British Journal of Cancer·J SchuetteC G Schmidt
Mar 1, 1985·Cancer Treatment Reviews·W P BradeM Varini
Oct 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J R Daniels
Oct 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S R SmalleyJ D Earle
Jan 1, 1984·Acta Obstetricia Et Gynecologica Scandinavica. Supplement·B Sandström
Oct 1, 1980·The Journal of Urology·P H LangeJ M Streitz
Dec 1, 1982·Cancer·D BallM J Peckham
Feb 1, 1984·Klinische Wochenschrift·C ClemmW Wilmanns
May 1, 1984·Cancer·A G CockburnW F Whitmore
Jan 1, 1984·The Journal of Urology·D A SwartzD H Hussey
Apr 1, 1983·The Journal of Urology·E D CrawfordJ B deKernion
Dec 1, 1980·Cancer Nursing·F Pilapil, K V Studva
Feb 1, 1982·International Journal of Radiation Oncology, Biology, Physics·G M ThomasC W Keen

❮ Previous
Next ❯

Citations

Feb 15, 2001·Microscopy Research and Technique·C BeckD Rowley
Aug 30, 1995·International Journal of Radiation Oncology, Biology, Physics·T W SpeerR R Million
Apr 1, 1996·Critical Reviews in Oncology/hematology·S CulineJ P Droz
Oct 6, 1997·International Journal of Radiation Oncology, Biology, Physics·H SchmidbergerW Haase
Jul 9, 2002·Journal of Cutaneous Pathology·J Andrew CarlsonStephen M Prouty
Nov 26, 2002·Pathology International·Hiroshi TakahashiShin-ichi Nakamura
Feb 7, 1998·Proceedings of the National Academy of Sciences of the United States of America·R G WeberP Lichter
Oct 29, 2004·Neurosurgery·John Y K LeeBennett Omalu
May 24, 2001·In Vitro Cellular & Developmental Biology. Animal·H W RheeL W Chung
Aug 18, 2004·Journal of Neurosurgery·Ossama Al-MeftyMuhammad Husain
Apr 26, 2014·British Journal of Cancer·J YanD Tang
Sep 30, 2003·Medical and Pediatric Oncology·Margherita Lo CurtoPaolo Tamaro
Sep 21, 2004·Oncogene·Muhammad Al-Hajj, Michael F Clarke
Sep 1, 1990·The Journal of Urology·S R SmalleyR L Richardson
Jan 3, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W J ReiterC Kratzik

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.